sAxl in CSF (n = 30/group) | ||||
---|---|---|---|---|
Cut off (nM) | Sensitivity % (95% CI) | Specificity % (95% CI) | LR+ | LR- |
0.02 | 100.00 (88.43 to 100.00) | 13.33 (3.76 to 30.72) | 1.15 | 0.00 |
0.09 | 90.00 (73.47 to 97.89) | 66.67 (47.19 to 82.71) | 2.70 | 0.15 |
0.10 | 86.67 (69.28 to 96.24) | 70.00 (50.60 to 85.27) | 2.89 | 0.19 |
0.11 | 76.67 (57.72 to 90.07) | 83.33 (65.28 to 94.36) | 4.60 | 0.28 |
0.12 | 73.33 (54.11 to 87.72) | 90.00 (54.11 to 87.72) | 7.33 | 0.30 |
0.14 | 63.33 (43.86 to 80.07) | 93.33 (77.93 to 99.18) | 9.50 | 0.39 |
sAxl in plasma (n = 20/group) | ||||
Cut off (nM) | Sensitivity % (95% CI) | Specificity % (95% CI) | LR+ | LR- |
0.4 | 100 (83.16 to 100.0) | 5 (0.1265 to 24.87) | 1.05 | 0.00 |
0.5 | 90 (68.30 to 98.77) | 15 (3.207 to 37.89) | 1.06 | 0.67 |
1 | 80 (56.34 to 94.27) | 45 (23.06 to 68.47) | 1.45 | 0.44 |
1.2 | 65 (40.78 to 84.61) | 65 (40.78 to 84.61) | 1.86 | 0.54 |
1.7 | 50 (27.20 to 72.80) | 80 (56.34 to 94.27) | 2.50 | 0.63 |